FDAT vs. AGOX ETF Comparison
Comparison of Tactical Advantage ETF (FDAT) to Adaptive Growth Opportunities ETF (AGOX)
FDAT
Tactical Advantage ETF
FDAT Description
The fund is an actively managed "fund-of ETFs." Family Dynasty Advisors LLC, the fund"s sub-adviser, invests the fund"s assets in ETFs that are listed on U.S. stock exchanges. The fund will invest in underlying ETFs that primarily invest in U.S. equity securities or high-yield bonds. Additionally, the fund will hold cash and cash equivalents.
Grade (RS Rating)
Last Trade
$22.67
Average Daily Volume
1,903
Number of Holdings
*
8
* may have additional holdings in another (foreign) market
AGOX
Adaptive Growth Opportunities ETF
AGOX Description
The investment seeks capital appreciation. The fund's portfolio manager seeks to achieve its investment objective of capital appreciation by investing in ETFs that are registered under the Investment Company Act of 1940, as amended and not affiliated with the fund that invest in equity securities of any market capitalization of issuers from a number of countries throughout the world, including emerging market countries. The manager primarily utilizes ETFs and equities but may also use fixed income securities to diversify its asset classes. The fixed income securities in which the fund will invest will be investment grade and may be of any duration or maturity.Grade (RS Rating)
Last Trade
$27.91
Average Daily Volume
31,768
Number of Holdings
*
70
* may have additional holdings in another (foreign) market
Performance
Period | FDAT | AGOX |
---|---|---|
30 Days | -0.01% | -3.12% |
60 Days | 1.14% | -0.96% |
90 Days | 5.98% | 3.38% |
12 Months | 16.67% | 23.39% |
FDAT Underweight 67 Positions Relative to AGOX
Symbol | Grade | Weight | |
---|---|---|---|
LLY | F | -7.78% | |
AMZN | A | -7.22% | |
QQQ | B | -6.79% | |
BSX | C | -4.57% | |
AVGO | B | -2.82% | |
HWM | B | -2.1% | |
AAPL | C | -2.02% | |
MSFT | D | -1.6% | |
CRM | A | -1.5% | |
PGR | D | -1.28% | |
GE | D | -1.22% | |
DECK | B | -1.13% | |
VRT | B | -1.11% | |
VRTX | D | -1.1% | |
SMCI | F | -1.1% | |
KCE | B | -1.08% | |
VRSK | B | -1.05% | |
FICO | B | -0.99% | |
GWW | A | -0.91% | |
CEG | B | -0.91% | |
BMI | D | -0.82% | |
T | A | -0.82% | |
ETN | B | -0.82% | |
TDG | C | -0.81% | |
CPRT | D | -0.81% | |
NVO | F | -0.8% | |
CRS | B | -0.77% | |
APPF | D | -0.77% | |
REGN | F | -0.74% | |
INTC | C | -0.72% | |
MMS | D | -0.63% | |
CBOE | B | -0.62% | |
SPSC | F | -0.57% | |
ARGT | A | -0.52% | |
ANF | F | -0.47% | |
PTGX | B | -0.45% | |
IR | C | -0.43% | |
AMP | B | -0.42% | |
AMD | F | -0.41% | |
BKNG | A | -0.4% | |
RJF | A | -0.36% | |
IESC | A | -0.36% | |
MOG.A | C | -0.36% | |
JPM | A | -0.32% | |
ECL | C | -0.29% | |
TYL | A | -0.29% | |
FSS | F | -0.28% | |
AI | C | -0.27% | |
GRBK | D | -0.27% | |
HUBB | B | -0.26% | |
TPH | D | -0.26% | |
MDGL | A | -0.24% | |
BAC | B | -0.23% | |
META | B | -0.23% | |
SCHW | B | -0.22% | |
SWKS | F | -0.21% | |
MANH | D | -0.2% | |
WINA | A | -0.2% | |
AROC | D | -0.2% | |
PWR | B | -0.13% | |
NVDA | B | -0.12% | |
TSLA | A | -0.05% | |
XOM | C | -0.02% | |
MPC | F | -0.01% | |
ADI | C | -0.01% | |
ORCL | B | -0.01% | |
OGIG | A | -0.0% |
FDAT: Top Represented Industries & Keywords
Industries:
Keywords:
Exchange Traded Fund
ETF
Index Fund
Stock Market Index
Aerospace
Barclays
Betashares
Bloomberg Barclays Us Aggregate Bond Index
Bond
Cash And Cash Equivalents
Credit Risk
Defense Industry
Depositary Receipt
Dow Jones Global Indexes
Dow Jones Industrial Average Index
Dow Jones U.S. Total Stock Market Index
Exchange Traded Funds
Global Industry Classification Standard
Interactive Media
Investment Management
AGOX: Top Represented Industries & Keywords
Industries:
Semiconductors
Biotechnology
Software - Application
Software - Infrastructure
Specialty Industrial Machinery
Aerospace & Defense
Banks - Global
Business Services
Capital Markets
Engineering & Construction
Specialty Retail
Apparel Stores
Asset Management
Auto & Truck Dealerships
Auto Manufacturers
Computer Hardware
Conglomerates
Consumer Electronics
Diversified Industrials
Drug Manufacturers - Major